Skip navigation
Skip navigation

Cost-effectiveness of dual-energy X-ray absorptiometry plus antiresorptive treatment in Australian women with breast cancer who receive aromatase inhibitors

Sowa, Marcin; Downes, Martin J.; Gordon, Louisa


Postmenopausal women with breast cancer on aromatase inhibitor (AI) treatment are at increased risk of bone mineral density loss, which may lead to minimal trauma fractures. We examined the cost-effectiveness of dual energy X-ray absorptiometry (DXA) with antiresorptive (AR) therapy compared with fracture risk assessment, lifestyle advice, and vitamin supplementation. We used a hypothetical Markov cohort model of lifetime duration for 60-year-old women with early stage breast cancer receiving...[Show more]

CollectionsANU Research Publications
Date published: 2017
Type: Journal article
Source: Journal of Bone and Mineral Metabolism
DOI: 10.1007/s00774-016-0742-2


File Description SizeFormat Image
01_Sowa_Cost-effectiveness_of_2017.pdf1.88 MBAdobe PDFThumbnail
    Request a copy

Items in Open Research are protected by copyright, with all rights reserved, unless otherwise indicated.

Updated:  19 May 2020/ Responsible Officer:  University Librarian/ Page Contact:  Library Systems & Web Coordinator